About Nirvana Life Science
Nirvana Life Science is a company based in Vancouver (Canada) founded in 2021. Nirvana Life Science has completed 1 acquisition, including MedSmart Staffing. Nirvana Life Science offers products and services including Psilocybin Formulations and Addiction Treatment Therapies. Nirvana Life Science operates in a competitive market with competitors including Entheon Biomedical, Clairvoyant Therapeutics and Alvarius, among others.
- Headquarter Vancouver, Canada
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nirvana Life Sciences Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$150 K (USD), Post-IPO
Jun 15, 2022
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Nirvana Life Science
Nirvana Life Science is a publicly listed company on the CSE with ticker symbol NIRV in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Nirvana Life Science
Nirvana Life Science offers a comprehensive portfolio of products and services, including Psilocybin Formulations and Addiction Treatment Therapies.
Medicines to break opioid addiction and provide non-addictive pain relief.
Formulations targeting anxiety, depression, and addiction using psychedelics.
Funding Insights of Nirvana Life Science
Investors in Nirvana Life Science
Nirvana Life Science has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include ThreeD Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Locked | Locked | Locked |
Investor details for Nirvana Life Science
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nirvana Life Science
Nirvana Life Science has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MedSmart Staffing.
Investment portfolio details for Nirvana Life Science
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Staffing services for the medical imaging industry are provided.
|
Locked | Locked | 2001 | Locked |
Complete acquisition details for Nirvana Life Science
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Nirvana Life Science
Detailed financials for Nirvana Life Science
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nirvana Life Science Comparisons
Peer comparison for Nirvana Life Science
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nirvana Life Science
Nirvana Life Science operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Entheon Biomedical, Clairvoyant Therapeutics and Alvarius, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Psychedelic medicines for addiction disorders are developed and patented.
|
|
| Locked | Locked | Locked |
Psychedelic therapy drugs for addiction treatment are manufactured.
|
|
| Locked | Locked | Locked |
Develops bio-pharmaceutical treatments for addiction via psychedelics and therapy.
|
Detailed competitors of Nirvana Life Science
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nirvana Life Science
Complete news archive for Nirvana Life Science
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nirvana Life Science
Nirvana Life Science was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Nirvana Life Science is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Bruce Clark is the current CEO of Nirvana Life Science.
Developer of therapeutics for the treatment of opioid addiction. The company focuses on developing novel therapeutic products derived from psychedelics for pain management as well as treatment for ailments such as addiction, anxiety, and depression. The companys products inlcude a one-per-day gel cap that assists transition from opioids to non-addictive pain relief therapies.
Nirvana Life Science's top competitors include Clairvoyant Therapeutics, Entheon Biomedical and Alvarius.
Nirvana Life Science offers Psilocybin Formulations and Addiction Treatment Therapies.
Yes, Nirvana Life Science is publicly traded on CSE under the ticker symbol NIRV.
Nirvana Life Science has made 1 acquisition, including MedSmart Staffing.
Nirvana Life Science has 1 investor. Key investors include ThreeD Capital.
The ticker symbol of Nirvana Life Science is NIRV on CSE.